HRT may prevent endometrial cancerJuly 31, 2002The long-term use of hormone replacement therapy (HRT) does not increase the risk of endometrial cancer and may even protect the endometrium (the lining of the uterus) from the disease, concludes a study in this week's BMJ. In one of the largest long-term studies of its kind researchers from across the UK collected data from 534 postmenopausal women. Before the study began, 364 of the women had taken oestrogen and progestogen hormone replacement therapy in which the two hormones were given sequentially, 164 had not used hormone replacement therapy and 10 had taken oestrogen only hormone replacement therapy. The women were placed on a course of continuous combined HRT. Biopsy samples were then taken from the women before they started to take the combined HRT, after nine months, and between 24-36 months and at the end of the five year study. Before the research began, 21 women were noted as having abnormal endometrium, which when associated with other cellular changes can be an early sign of cancer, but following nine months of continuous combined HRT, the endometrium had reverted to normal. No cases of endometrial cancer developed during the study. Women who take daily combined HRT may actually be better protected against endometrial cancer than women who do not use any form of hormone replacement therapy, they conclude. | |||||||||||||||||||||
|
Related Estrogen Current Events and Estrogen News Articles Why the 'perfect' body isn't always perfect Having an imperfect body may come with some substantial benefits for some women, according to a new article in the December issue of Current Anthropology. Estrogen therapy could be dangerous for women with existing heart risk Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. Migraines associated with lower risk of breast cancer Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Scientists identify new gene responsible for puberty disorders A new gene responsible for some puberty disorders has been identified by Medical College of Georgia researchers. Birth control has long-term effect on hormone exposure Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life. Clue to genetic cause of fatal birth defect A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine. Bisphenol A linked to chemotherapy resistance Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. Tamoxifen chemoprevention tied to early detection of breast cancer The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute. Herbal Menopause Therapy a Good Fit for Breast Cancer Patients? When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer. More Estrogen Current Events and Estrogen News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||